
Long Term Follow‐up Data and Health‐Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG)
Author(s) -
Kutsch Nadine,
Bahlo Jasmin,
Robrecht Sandra,
Franklin Jeremy,
Zhang Can,
Maurer Christian,
De Silva Nisha,
Lange Elisabeth,
Weide Rudolf,
Kiehl Michael G.,
Sökler Martin,
Schlag Rudolf,
VehlingKaiser Ursula,
Köchling Georg,
Plöger Christoph,
Gregor Michael,
Plesner Torben,
Herling Marco,
Fischer Kirsten,
Döhner Hartmut,
Kneba Michael,
Wendtner ClemensMartin,
Klapper Wolfram,
Kreuzer KarlAnton,
Böttcher Sebastian,
Stilgenbauer Stephan,
Fink Anna Maria,
Hallek Michael,
Eichhorst Barbara
Publication year - 2020
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/hs9.0000000000000336
Subject(s) - medicine , rituximab , gastroenterology , hazard ratio , clinical endpoint , fludarabine , statistical significance , cyclophosphamide , surgery , progression free survival , chronic lymphocytic leukemia , quality of life (healthcare) , randomized controlled trial , confidence interval , leukemia , chemotherapy , lymphoma , nursing
Supplemental Digital Content is available in the text